1. Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. Issue 9 (September 2015) Authors: Kohli, Anita; Kapoor, Rama; Sims, Zayani; Nelson, Amy; Sidharthan, Sreetha; Lam, Brian; Silk, Rachel; Kotb, Colleen; Gross, Chloe; Teferi, Gebeyehu; Sugarman, Kate; Pang, Phillip S; Osinusi, Anu; Polis, Michael A; Rustgi, Vinod; Masur, Henry; Kottilil, Shyam Journal: Lancet infectious diseases Issue: Volume 15:Issue 9(2015:Sep.) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. Issue 9 (September 2015) Authors: Kohli, Anita; Kapoor, Rama; Sims, Zayani; Nelson, Amy; Sidharthan, Sreetha; Lam, Brian; Silk, Rachel; Kotb, Colleen; Gross, Chloe; Teferi, Gebeyehu; Sugarman, Kate; Pang, Phillip S; Osinusi, Anu; Polis, Michael A; Rustgi, Vinod; Masur, Henry; Kottilil, Shyam Journal: Lancet infectious diseases Issue: Volume 15:Issue 9(2015:Sep.) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗